Altimmune (ALT) Operating Leases (2015 - 2026)
Altimmune (ALT) posted quarterly Operating Leases of $1.1 million for Q1 2026, down 19.75% year-over-year from $1.3 million in Q1 2025, and down 5.94% quarter-over-quarter from $1.1 million in Q4 2025.
Altimmune (ALT) Operating Leases (2015 - 2026) Analysis & Trends
Altimmune (ALT) has reported Operating Leases for 7 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 19.75% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 19.75% YoY), while the FY2025 annual figure was $1.1 million, down 18.33% from the prior year.
- Operating Leases slipped to $1.1 million in Q1 2026 per ALT's latest filing, from $1.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $1.5 million in Q2 2024 and bottomed at $44000.0 in Q1 2024.
- Historically, Operating Leases has averaged $1.0 million across 5 years, with a median of $1.2 million in 2025.
- Annual changes were most pronounced in 2023 — Operating Leases sank 73.96% — and 2025, when it jumped 2950.0%.
- Altimmune's Operating Leases stood at $672000.0 in 2022, then sank by 73.96% to $175000.0 in 2023, then jumped by 701.14% to $1.4 million in 2024, then dropped by 18.33% to $1.1 million in 2025, then fell by 5.94% to $1.1 million in 2026.
- Business Quant data shows ALT's Operating Leases at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 175,000.00 |
| Dec 31, 2022 | 672,000.00 |
| Mar 31, 2016 | 43,809.00 |
| Dec 31, 2015 | 108,641.00 |
| Sep 30, 2015 | 184,018.00 |